Cancer Cervix
10
3
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
20%
2 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Tomotherapy vs Conventional Radiation for Adjuvant Pelvic RT in Ca Cervix
Vaginal Self-sampling and Human Papillomavirus Testing in Unscreened Women
Building Connections
Enhancing Cancer Prevention and Control Pathways-Native Health Initiative
Genomic Testing and Resulting Medical Decisions
Role Of Colposcopy In Evaluation Of Suspicious Cervix
Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients
ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer
Image Guided Brachytherapy in Locally Advanced Cancer Cervix
Carrying Out of Focus Group to Improve Cervical Screening Proposal by Vaginal Self-sampling (APACHE-4/FG).